A similar experimental design was employed to assess the impact of low‐sucrose (7% sucrose), or high‐sucrose diet (30%), in AML FLT3‐ITD‐bearing mice and found that survival appeared extended in the low‐sucrose + doxorubicin treatment group, but did not reach statistical significance (p = 0.2) (Figure 1C). The gene discussed is FLT3; the disease is acute myeloid leukemia.